Target intelligence / Profile preview

Influenza A virus hemagglutinin (HA) stem region (HA stem)

Target
HA stem
Molecular classification
Viral surface glycoprotein, Class I fusion protein, Antigen
01

Overview

The Influenza A virus hemagglutinin (HA) stem region is a highly conserved structural domain of the viral surface glycoprotein, essential for mediating the fusion between the viral envelope and the host cell endosomal membrane (Corti et al., Science, 2011). While the globular head of HA frequently mutates to evade the immune system, the stem region remains relatively invariant across both Group 1 (e.g., H1, H5) and Group 2 (e.g., H3, H7) influenza A subtypes, making it a primary target for universal vaccine and therapeutic design (Dreyfus et al., Science, 2012). Upon exposure to the acidic environment of the endosome, the HA stem undergoes a massive conformational rearrangement that pulls the viral and host membranes together. Therapeutic agents, particularly broadly neutralizing antibodies (bnAbs) like MEDI8852 and FI6v3, bind to this region and physically lock the protein in its pre-fusion state, thereby preventing viral entry and infection (Kallewaard et al., Cell, 2016). This target is currently the focus of intensive research to develop long-lasting, cross-protective countermeasures against seasonal and pandemic influenza threats (Impagliazzo et al., Science, 2015). The development of small molecules like JNJ-4796 also demonstrates the feasibility of targeting this region with non-biologic inhibitors (van Dongen et al., Science, 2019).

Other names
Hemagglutinin stalkHA stalkHA2 subunitConserved HA stem regionInfluenza A HA stalk
02

Mechanism of action

Binding to the conserved stem region of hemagglutinin to inhibit the pH-induced conformational change required for viral-host membrane fusion.

03

Biological functions

Viral entryMembrane fusionViral penetration
04

Disease associations

InfectionInfluenza APandemic influenza
05

Safety considerations

Viral escape mutationsAntibody-dependent enhancement (ADE)Low natural immunogenicity
06

Interacting drugs

MEDI8852

5 more in the full profile.

07

Biomarkers

Anti-HA stem antibody titersViral loadMicroneutralization assay titers

Beyond the preview

Go deeper on Influenza A virus hemagglutinin (HA) stem region (HA stem).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Influenza A virus hemagglutinin (HA) stem region (HA stem).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call